SBFM
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trades at a massive discount to assets, but assets may be impaired or non-productive.
- P/B of 0.22
- P/S of 0.14
- No P/E ratio
- No Graham Number available
Growth metrics are negative across both YoY and Q/Q timeframes.
- Revenue growth -10.60%
- Q/Q Revenue growth -10.61%
- Negative profit margins
Historical price performance indicates a total loss of investor confidence.
- 5Y Change -100%
- 3Y Change -99.9%
- 6M Change -50.7%
Liquidity is present, but operational health is critical.
- Low Debt/Equity
- High Current Ratio
- Piotroski F-Score 1/9
- Negative ROE (-25.68%)
Non-dividend paying growth/speculative stock.
- No dividend paid
- 0/100 Dividend Strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for SBFM and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
SBFM
Sunshine Biopharma, Inc.
Primary
|
-100.0% | -99.9% | -17.6% | -50.7% | -6.4% | +3.2% |
|
CLGN
CollPlant Biotechnologies Ltd.
Peer
|
-97.4% | -95.1% | -85.0% | -83.7% | -43.0% | -33.0% |
|
INBS
Intelligent Bio Solutions Inc.
Peer
|
-100.0% | -99.3% | -79.8% | -77.0% | -39.7% | -10.6% |
|
MLEC
Moolec Science SA
Peer
|
-99.5% | -98.7% | -93.0% | -33.2% | -26.5% | -34.3% |
|
JAGX
Jaguar Health, Inc.
Peer
|
-100.0% | -100.0% | -92.8% | -82.2% | -34.7% | -7.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
SBFM
Sunshine Biopharma, Inc.
|
BEARISH | $5.05M | - | -25.7% | -16.5% | $1.03 | |
|
CLGN
CollPlant Biotechnologies Ltd.
|
BEARISH | $5.18M | - | -117.6% | -% | $0.36 | Compare |
|
INBS
Intelligent Bio Solutions Inc.
|
BEARISH | $4.92M | - | -150.2% | -% | $2.46 | Compare |
|
MLEC
Moolec Science SA
|
BEARISH | $5.46M | - | -% | -% | $7.52 | Compare |
|
JAGX
Jaguar Health, Inc.
|
BEARISH | $4.58M | - | -% | -% | $0.37 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-14 | NATAN DAVID | Director | Stock Award | 100,000 | - |
Past News Coverage
Recent headlines mentioning SBFM from our newsroom.